Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders
A legfontosabb adatok
- Ki végzi
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Hol
- Pittsburgh (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 12 fő vett részt
- Kezdés
- 2021. júl. 1.
- Befejezés
- 2024. jan. 17.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- ARTSENS Pen
- A regiszteradat frissítve
- 2024. január 30.
- Miért állt le
- slow enrollment
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Csak nők
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Egyéb feltételek
- Case Inclusion Criteria:
- Adult females age > 18 years
- Must be able to read and understand English and consent for themselves
- Must have a singleton pregnancy and a diagnosis of preeclampsia or gestational hypertension
- Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks and then at 6-7 months; Case Exclusion Criteria:
- Prior history of hypertension
- Multiple pregnancies
- Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures; Control Inclusion Criteria:
- Adult females age > 18 years
- Must be able to read and understand English and consent for themselves
- Must have a singleton pregnancy and not have a prior or current diagnosis of hypertension
- Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks; Control Exclusion Criteria:
- Prior history and/or current diagnosis of hypertension
- Multiple pregnancies
- Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures
Helyszínek itt: Egyesült Államok
- West Penn HospitalPittsburgh, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a research study to understand the changes in the heart and the cardiovascular system that may occur in women who develop high blood pressure during pregnancy.
A vizsgálat 3 csoportja
- Pregnant with Pre-eclampsiaA vizsgált kezelés
There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit will be 6-7 months post partum where there is a collection of a clinical questionnaire, demographics, vitals, chart review, echocardiogram and vascular compliance will be re-measured.
Kezelés: ARTSENS Pen
- Pregnant with gestational hypertensionA vizsgált kezelés
There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit will be 6-7 months post partum where there is a collection of a clinical questionnaire, demographics, vitals, chart review, echocardiogram and vascular compliance will be re-measured.
Kezelés: ARTSENS Pen
- Pregnant without Hypertension - ControlMár használt kezelés, összehasonlításként
There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit is not applicable to the control group.
Kezelés: ARTSENS Pen
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2024. január 30.